StateViewPlusTM is a comprehensive Medicaid and State Pharmaceutical Assistance Program marketing intelligence solution that brings together census level prescription utilization data from over 40 state Medicaid agencies, 16 SPAPs, CMS quarterly Medicaid utilization data for all 50 states, and state formulary status to provide you with a greater understanding of Medicaid market trends down to the NDC-11 level.
StateViewPlus, the most comprehensive Medicaid and SPAPs market intelligence service available, gives you the ability to:
-
View quarterly data for 50 states and 16 SPAPs to examine the impact of Preferred Drug List and Prior Authorization status
-
Track competitive performance by absolute number and relative percent of market share by dollars, units, and Rxs at the NDC-11 level
-
Investigate market potential for new product launches with historical information back to year 2000
-
Assess the impact of new AMP reporting transparency as a result of the DRA
-
Evaluate potential return of promotional efforts and supplemental rebate contracts
-
Determine the impact of generic substitutions and multi-state purchasing pools
-
Monitor utilization of the top 20 physicians administered drugs as states comply with DRA requirements
As more and more States implement changes to their programs and growth projections become reality, monitoring and anticipating these changes is critical and necessary to your overall understanding and positioning in the marketplace.